Webinars

Cellular reprogramming to enable the precise and scalable manufacturing of human cells for therapeutic applications

2021

Dr Alex Davenport, Senior Scientist, bit.bio
Cell & Gene Therapy
bit.bio talk at ELRIG

CRISPR and the art of perturbation screening: Unbiased functional genomic screening meets the best human cellular models

2021

Kam Dhaliwal, SVP Strategic Alliances, bit.bio
CRISPR in Drug Discovery
bit.bio talk at ELRIG

Introducing human iPSC derived muscle cells for research and drug discovery

2020

Dr Will Bernard, Senior Scientist, bit.bio
Dr Luke Flatt, Senior Scientist, Charles River
bit.bio

Consistent and scalable human iPSC-derived cells for in vitro disease modelling and drug discovery

2020

Kam Dhaliwal, SVP Strategic Alliances, bit.bio
Dr Thomas Moreau, Head of Research, bit.bio
bit.bio talk at ELRIG

Solving the R&D efficiency conundrum within drug discovery: Thoughts, insights and solutions

2020

bit.bio, AstraZeneca, PhoreMost Ltd, Aelian Biotechnology, Charles River Laboratories
bit.bio panel discussion at ELRIG

Advances in cellular reprogramming: from stem cells to printed tissues

2020

Prof Hagan Bayley, University of Oxford
Dr Mark Kotter, Founder and CEO, bit.bio
bit.bio

Discover more resources

Journals

Posters

Videos

Webinars